Donhuijsen K, Eimermacher H, Lunscken C, Metz K, Leder L D
Zentralbl Allg Pathol. 1980;124(4):314-24.
In the last years angioimmunoblastic lymphadenopathy (AIL) was interpreted mainly as a benign reactive lymphnode disease. Recently, the reports about a progression into malignant lymphomas have become more numerous. We present a case of a 74-years-old woman which was diagnosed as lymphogranulomatosis X at first. Four weeks later criteria of malignancy were evident. 7 months after beginning of the disease the patient died. Histological, cytochemical, cytophotometrical, electron microscopical and immunological findings are reported. With regard to the diagnosis AIL it must be kept in mind that an evolution into malignant lymphoma is not infrequent. Hereby obviously a variable differentiation can be expected.
在过去几年中，血管免疫母细胞性淋巴结病（AIL）主要被解释为一种良性反应性淋巴结疾病。最近，关于其进展为恶性淋巴瘤的报道越来越多。我们报告一例74岁女性病例，最初被诊断为X线淋巴肉芽肿病。四周后，恶性肿瘤的标准明显。疾病开始7个月后，患者死亡。报告了组织学、细胞化学、细胞光度学、电子显微镜和免疫学检查结果。关于AIL的诊断，必须记住其进展为恶性淋巴瘤并不罕见。因此，可以预期会有明显的可变分化。
